UnitedHealth Extends Amedisys Merger Deadline Amid DOJ Antitrust Challenge
UnitedHealth Group extends the deadline for its $3.3 billion Amedisys acquisition as DOJ raises antitrust concerns; Amedisys shares rise 4.7% pre-market.
UnitedHealth Group Inc. is involved in a merger with Amedisys Inc. facing antitrust challenges.